Influence of mycophenolate mofetil dosage and plasma levels on the occurrence of chronic lung allograft dysfunction in lung transplants: a retrospective cohort analysis
INTRODUCTION: Development of chronic lung allograft dysfunction is a limiting factor for post-lung transplant survival. We evaluated whether the dose of the immunosuppressant mycophenolate mofetil or plasma concentrations of the active metabolite mycophenolic acid affect the development of chronic...
Main Authors: | Carolin Steinack, Philipp Saurer, Fiorenza Gautschi, René Hage, Gernot Ortmanns, Macé M. Schuurmans, Thomas Gaisl |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2022-07-01
|
Series: | Swiss Medical Weekly |
Online Access: | https://smw.ch/index.php/smw/article/view/3232 |
Similar Items
-
Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19
by: René Hage, et al.
Published: (2021-06-01) -
Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures
by: Carolin Steinack, et al.
Published: (2022-06-01) -
Calcineurin inhibitors revisited: A new paradigm for COVID-19?
by: René Hage, et al.
Published: (2020-07-01) -
Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01) -
COVID-Related Chronic Allograft Dysfunction in Lung Transplant Recipients: Long-Term Follow-up Results from Infections Occurring in the Pre-vaccination Era
by: René Hage, et al.
Published: (2022-09-01)